Browse the evidence

A prática de exercício físico, em conjunto com a alimentação saudável, pode prevenir doenças crônicas e contribuir para a manutenção ou alcance do peso saudável.

Profissionais devem considerar a combinação de exercício e nutrição para promover a saúde.

For the low-carbohydrate diet, race, body fat percentage, and fasting glucose at baseline are significant predictors of weight loss success.

Practitioners should consider these factors when recommending low-carbohydrate diets.

Reducing carbohydrate intake in exchange for more protein and fat improves glucose metabolism in patients with type 2 diabetes and can enable diabetes remission in a high percentage of cases.

Practitioners may consider recommending a low-carbohydrate diet to improve glucose control in type 2 diabetes patients.

Carbohydrate restriction significantly improves triglyceride-rich lipoproteins and non-HDL cholesterol while increasing HDL cholesterol.

Practitioners should note the positive effects of carbohydrate restriction on lipid profiles in type 2 diabetes patients.

Intervention studies show an improvement in cardiovascular risk profiles in patients with type 2 diabetes due to carbohydrate reduction.

Practitioners may consider the cardiovascular benefits of carbohydrate reduction in managing type 2 diabetes.

Resistance training significantly reduced glycemic levels in pregnant women from 122 ± 8.5 mg/dl to 105 ± 7.2 mg/dl (p=0.012).

Incorporating resistance training into prenatal care may help manage glycemic levels in pregnant women.

Eccentric Training (ET) leads to a 6% greater reduction in body fat percentage compared to Concentric Training (CT) and a 19% greater reduction compared to the Control Group (CG).

Incorporating eccentric training may be more effective for reducing body fat in older adults.

Post-exercise recovery is fundamental to the adaptation process.

Practitioners should emphasize the importance of recovery in training programs.

Participants with higher sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) intake and lower physical activity were independently at higher risk of type 2 diabetes (T2D).

Reducing intake of SSBs and ASBs while increasing physical activity may lower the risk of developing T2D.

Participants who did not meet physical activity guidelines and consumed more than 2 servings/day of SSBs had a significantly higher risk of T2D compared to those who met physical activity guidelines and never/rarely consumed SSBs.

Encouraging adherence to physical activity guidelines is crucial, especially for those consuming high amounts of SSBs.

Even among participants who met physical activity guidelines, those who consumed more than 2 servings/day of SSBs had a higher risk of T2D.

Limiting SSB intake is important for reducing T2D risk, even for those who are physically active.

Twins on the healthy vegan diet had a greater reduction in LDL cholesterol after 8 weeks compared to those on the healthy omnivorous diet (-15.2 vs. -2.3 mg/dL).

A vegan diet may be more effective than an omnivorous diet for lowering LDL cholesterol.

FDA-approved anti-obesity medications can facilitate weight loss and enhance metabolic indices.

Practitioners can recommend these medications for weight management in obese patients.

The reduction of excess body fat is crucial for the treatment of type 2 diabetes.

Weight loss strategies should be prioritized in diabetes management plans.

Obesity is a primary driver for the development of type 2 diabetes.

Weight loss interventions should be prioritized in managing patients with type 2 diabetes.

Obesity is recognized as a chronic, progressive condition requiring early intervention and long-term management.

Practitioners should prioritize early intervention and long-term strategies in managing obesity.

Pharmacotherapy is highly effective in reducing body weight and improving metabolic parameters.

Pharmacotherapy should be considered as a key component in obesity treatment plans.

Baseline metabolic health predicts weight-loss outcomes and recurrence risk.

Assessing baseline metabolic health can guide individualized treatment plans for bariatric surgery patients.

Tailored cardiac rehabilitation programs integrating individualized exercise, nutritional support, and pharmacotherapy show short-term benefits.

Implementing tailored CR programs can enhance short-term outcomes for obese patients.

Incretin polyagonists significantly reduced body weight compared to placebo (MD -11.47; 95% CI: -14.00 to -8.95).

Incretin polyagonists can be considered effective for weight management in obese patients.

Significant reductions were observed in waist circumference (MD -9.40; 95% CI: -11.91 to -6.89).

Incretin polyagonists may help reduce waist circumference in obese individuals.

Precision nutrition may mitigate adverse effects and weight recovery during pharmacotherapy.

Incorporating precision nutrition can enhance the effectiveness of obesity treatments.

Metabolic therapies like tirzepatide can reduce weight and improve OSA severity.

Incorporating metabolic therapies may enhance treatment strategies for patients with obesity and OSA.

Protein ingestion increased circulating plasma amino acid concentrations.

Protein supplementation can effectively elevate amino acid levels in the bloodstream post-exercise.